Anixa Biosciences, Inc. (ANIX) Dividend History

Anixa Biosciences, Inc. is a biotechnology company focused on the development of cancer immunotherapies and infectious disease vaccines. The company leverages its immuno-oncology platform to create targeted treatments aimed at improving patient outcomes, with a particular emphasis on cancer vaccines and therapies.

3150 Almaden Expressway, Suite 250, San Jose, CA, 95118
Phone: 408-708-9808
Website: https://www.anixa.com

Dividend History

Anixa Biosciences, Inc. currently does not pay dividends

Company News

Anixa Biosciences to Present at the Sidoti Micro-Cap Virtual Conference on November 13 & 14, 2024

Anixa Biosciences, a biotechnology company focused on cancer treatment and prevention, will present at the Sidoti Micro-Cap Virtual Conference on November 13-14, 2024. The company will provide updates on its breast cancer and ovarian cancer clinical trials, which have been producing positive results.

Benzinga
Autonomix secures RF Innovations technology license By Investing.com - Investing.com

Anixa Biosciences, a biotechnology company, has announced a $5 million stock buyback program, signaling confidence in its financial health and future prospects.

Investing.com
Dermata (DRMA) Up on FDA Nod to Begin Pivotal Study of Acne Drug

Dermata (DRMA) announces reaching an agreement with the FDA to begin a late-stage pivotal clinical program for its acne treatment candidate, DMT310. The stock rises 7%.

Zacks Investment Research

Featured Companies: ACAD DRMA LGND

Page data last updated 07/23/2025 17:00:40 UTC